Intruder Alert

Dr Helen Whitby at Phenomenex explores new research revealing liquid chromatography-tandem mass spectrometry may be the solution to prevent contaminates, such as host cell proteins, stopping a drug from progressing to clinical trials.

Dr Helen Whitby at Phenomenex (October 2017)

Keywords: Host cell proteins, Identifying contaminates, Monoclonal antibodies, Purification

View full article    |    Back to Biopharma section